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NF-κB p65 directs sex-specific 
neuroprotection in human neurons
Lucia M. Ruiz-Perera1, Lennart Schneider1, Beatrice A. Windmöller1, Janine Müller1, 
Johannes F. W. Greiner  2, Christian Kaltschmidt2 & Barbara Kaltschmidt1,2
Protection of neurons against oxidative stress is crucial during neuronal development, maintenance 
and for treating neurodegenerative diseases. However, little is known about the molecular mechanisms 
underlying sex-specific maturation and survival of neurons. In the present study, we demonstrate 
NF-κB-p65 mediated neuroprotection in human glutamatergic neurons differentiated from inferior 
turbinate stem cells (ITSCs) in a sex-dependent manner. We successfully differentiated ITSCs into MAP-
2+/NF200+/Synaptophysin+/vGlut2+-glutamatergic neurons in vitro and ex vivo and validated their 
functionality. TNF-α-dependent NF-κB-p65 activation was accompanied by significant neuroprotection 
against oxidative stress-induced neuronal death, which was surprisingly higher in neurons from female 
donors. Accordingly, sex-specific neuroprotection of female neurons was followed by an increased 
expression of special NF-κB target genes SOD2 and IGF2. Among these, SOD2 is a well known gene 
protecting cells against oxidative stress resulting in longevity. In addition, IGF2 is known to promote 
synapse formation and spine maturation, and it has antioxidant and neuroprotective effects against 
oxidative damage. In conclusion, we show that NF-κB-p65 is a key player in neuroprotection of human 
neurons, however the protective gene expression program beneath it differs between sexes. Our 
findings are in accordance with the increasing evidences pointing towards sex-specific differences in risk 
and severity of neurodegenerative diseases.
Acute and chronic nervous system damage in response to an insult such as oxidative stress is directly associated to 
neuronal death and degeneration1. Thus, appropriate neuroprotection remains as a crucial parameter for effective 
treatment of neurodegenerative diseases. Interestingly, increasing evidences point towards sex-specific differ-
ences in risk, severity and progression of neurodegenerative diseases such as Parkinson’s (PD) or Alzheimer’s 
disease (AD) or in case of Ischemic stroke2–4. In particular, female AD patients were reported to not only have 
an increased risk of developing AD compared to age-matched men5, but also showed a significantly elevated 
age-related decline of cognition3,6. On the contrary, PD was shown to have a greater prevalence and occurred in 
an earlier age in men compared to woman2. Although neurodegenerative diseases and preventive neuroprotective 
mechanisms7 seem to be subjected to sex-dependent differences, little is known about the underlying molecular 
mechanisms particularly regarding maturation and survival of neurons differentiated from human stem cells.
The transcription factor NF-κB (nuclear factor kappa-light-chain-enhancer of activated B-cells) is involved 
in a broad range of cellular processes such as cell survival, growth, stress, immune and inflammatory responses8. 
Within the murine nervous system, the NF-κB heterodimers c-Rel/p65 and p50/p65, and p50 homodimers play 
an important role during development9, while the activity of p50/p65 was shown to be predominant in the adult 
brain10. Activation of NF-κB can be triggered by multiple stimuli such as cytokines like tumour necrosis factor-α 
(TNF-α) or neurotransmitters like AMPA or glutamate in mouse and rat cerebellar granule cells11,12. In murine 
neurons, NF-κB signalling and its target genes are involved in neuroprotection/degeneration13, neurite growth14, 
the formation of dendritic spines and their functionality15, axonal outgrowth16 and synaptic plasticity17,18. 
Activation of NF-κB in human and murine cells is also known to be caused by oxidative stress, an increase in 
intracellular reactive oxygen species (ROS) such as H2O2, superoxide (O2−), or hydroxyl radical (OH)19. Whithin 
the nervous system, oxidative stress leads to activation of NF-κB with a direct linkage to several neurological dis-
eases and brain damage20. In functional neurons from humans or mice, activation of various glutamate receptors 
also induces oxidative stress21. On the contrary, reactive oxygen intermediate hydrogen peroxide (H2O2) is known 
to act as a second messenger despite its cytotoxicity20,22. In primary rat cerebellar granule cells, the direct exog-
enous addition of H2O2 to culture medium activates NF-κB23, as well as it was observed previously in different 
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human cell lines22,24,25. In human and mouse embryonic stem cells, metabolic oxidation is known to directly 
regulate cell differentiation26. Maintenance of redox balance was further shown to be crucial for stemness and 
self-renewal of hematopoietic stem cells (HSCs) and neural stem cells (NSCs)27 from mice and humans. On the 
other hand, NF-κB signalling is directly linked to proliferation of rat NSCs28 and early neuronal differentiation of 
mouse NSCs29, although its direct role in protection of human stem cell-derived neurons against oxidative stress 
still remains unclear.
In the present study, we demonstrate a neuroprotective role of NF-κB-p65 through maturation of human 
glutamatergic neurons derived from neural crest-derived stem cells (NCSCs) after oxidative stress insult. During 
vertebrate development, neural crest cells migrate from the border between neural plate and non-neural ecto-
derm and give rise to a wide variety of cell types like neurons, glial cells, or melanocytes30. Pursuing their role 
in development, neural crest cells also persist into adulthood as NCSCs within various tissues, including skin31, 
cornea32, periodontal ligament33, palate34 and pulp of teeth35. A particularly interesting population of NCSCs has 
been found within the respiratory epithelium in the inferior turbinate of the human nose. Inferior turbinate stem 
cells (ITSCs) are able to differentiate into a wide variety of cell types from mesodermal and neuro-ectodermal 
lineages, such as chondrocytes, osteocytes, adipocytes, and glutamatergic as well as dopaminergic neurons36–38. 
Due to their capability to efficiently give rise to neuronal cell types, ITSCs harbor great potential for the treatment 
of neurodegenerative diseases38. Thus, ITSC-derived neurons served as an ideal model system for determining 
molecular mechanisms regulating maturation and survival of human neurons in the present study. We differenti-
ated ITSCs into MAP2+/NF200+/Synaptophysin+/vGlut2+-glutamatergic neurons, which we successfully stimu-
lated with AMPA or glutamate leading to activation of NF-κB-p65. TNF-α-dependent stimulation of NF-κB-p65 
in ITSC-derived neurons resulted in a significant neuroprotective effect against oxidative stress-induced cell 
death. ITSC-derived neurons from female donors further showed a significantly elevated sensitivity to H2O2 as 
well as a 2-fold increase in TNF-α-dependent neuroprotection compared to neurons from male donors. Our find-
ings reveal NF-κB-p65 as a key player in neuroprotection of NCSC-derived neurons in a sex-dependent manner, 
indicating the pivotal role of NF-κB-signalling during stem cell-based neuronal differentiation.
Results
Inferior turbinate stem cells efficiently differentiate into glutamatergic neurons in vitro. In 
order to gain an appropriate model system for studying the role of NF-κB in neuroprotection during matu-
ration of human NCSC-derived neurons, ITSCs were cultivated following a directed neuronal differentiation 
procedure for 30 days (Fig. 1a)36,38. Exposure of ITSCs to a neuronal induction medium for 28 days resulted in a 
neuronal-like morphology indicated by retraction of the cytoplasm towards the nucleus, and extended cellular 
processes resulting in neurite outgrowth (Fig. 1b–d). Immunocytochemical analyses confirmed the presence of 
the mature neuronal markers Neurofilament 200 (Fig. 1e,h; 92,28% ± 1,45%), MAP-2 (92,28% ± 4,20%; Fig. 1f,h) 
and Synaptophysin (75,77% ± 11,55%; Fig. 1i,h). Interestingly, 19,77% ± 6,85% of ITSC-derived neurons were 
positive for Calretinin (Fig. 1g,h), while a small subpopulation of 13,70% ± 8,74% differentiated ITSCs expressed 
the glial marker Olig-2 (Fig. 1h). Further validating their successful differentiation, only 20,96% ± 0,63% of ITSCs 
showed co-expression of Nestin (Fig. 1j) after directed differentiation. Accordingly, RT-PCR analyses depicted a 
decrease in expression of Nestin as well as an increased expression of MAP-2 and Synaptophysin in ITSC-derived 
neurons (Fig. 1i). Characterizing these neurons in more detail, we observed AMPA receptor subunit 1, NMDA 
receptor subunit 1, glutamate metabotropic receptor 1 (GRM1) as well as the vesicular glutamate transporter 1 
(VGLUT1) were robustly expressed (Fig. 1k). Immunocytochemistry further confirmed the glutamatergic phe-
notype of ITSC-derived neurons by revealing vGlut2-expression on the protein level (Fig. 1l,m).
Integration and differentiation of ITSC-derived glutamatergic neurons after transplantation 
into ex vivo-cultivated murine organotypic hippocampal slices. In addition to their efficient neu-
ronal differentiation in vitro, we evaluated the ability of ITSCs to integrate and differentiate within a neural 
environment by transplanting undifferentiated stem cells into murine organotypic hippocampal slices (Fig. 2a). 
Transplanted human ITSCs were able to integrate in the murine neural tissue and differentiated into MAP-2+ and 
Gat-1+ neurons after 14 days of co-cultivation (Fig. 2b,c). Furthermore, GFP-positive ITSCs integrated particu-
larly into the dentate gyrus of organotypic hippocampal slices, where they exhibited a clear neuronal phenotype 
accompanied by expression of vGlut2 and Synaptophysin on protein level (Fig. 2d–f). These findings confirmed 
that ITSCs are also able to give rise to excitatory glutamatergic neurons within the proper neural environment.
ITSC-derived glutamatergic neurons show AMPA or glutamate-dependent activation of 
NF-κB-p65. We next investigated the capability of ITSC-derived neurons to respond to the excitatory neu-
rotransmitter glutamate (GLU) or its agonist α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA). 
Stimulation with GLU or AMPA resulted in a significant increase in nuclear translocation of NF-κB-p65 in a 
dose-dependent manner (5–10 µM) in comparison to untreated neurons. On the contrary, treatment with 50 µM 
GLU or AMPA led to a significant decline in NF-κB-p65 nuclear translocation compared to 10 µM-treatment 
(Fig. 3a–d). We also observed high levels of basal NF-κB-activity (Fig. 3a–d), in accordance to the already 
described constitutive activation of NF-κB particularly in glutamatergic neurons39. Treatment of ITSC-derived 
neurons with their respective inhibitors 6-cyano-7-nitroquinoxaline-2, 3-dione (CQNX) or dibenzocyclohepte-
neimine (MK-801) prior to application of GLU (10 µM) or AMPA (10 µM) resulted in a significantly reduced 
translocation of NF-κB-p65 into the nucleus compared to the stimulation approaches (Fig. 3e,f). These findings 
provide pharmacological evidence that both kinds of receptors were expressed in human ITSC-derived glutama-
tergic neurons, which in turn were observed to be fully functional after 30 days of differentiation.
www.nature.com/scientificreports/
3SCieNtifiC RepoRtS |         (2018) 8:16012  | DOI:10.1038/s41598-018-34394-8
Figure 1. Adult human neural crest-derived stem cells from the inferior turbinate (ITSCs) are able to efficiently 
differentiate into glutamatergic neurons. (a) Schematic view of the neuronal differentiation procedure. (b–d) 
ITSCs changed their morphology towards a neuronal phenotype during directed neuronal differentiation. 
(e–g) Immunocytochemistry of ITSCs after 30 days of differentiation depicting the presence of positive cells 
for NF200, MAP-2 and calretinin (perinuclear region). (h) Quantification of immunocytochemical analyses 
showing the percentage of Synaptophysin+ (75,77% ± 11,55%), Calretinin+ (19,77% ± 6,85%), MAP-2+ 
(92,28% ± 4,20%), NF-200+ (92,28% ± 1,45%), Olig2+ (13,70% ± 8,74%) and Nestin+ (13,70% ± 0,63%) ITSC-
derived neurons after 30 days of neuronal differentiation (Mean ± SEM; n = 3). (I,j) Differentiated ITSCs 
were positive for Synaptophysin, while small population of cells remained Nestin-positive. (k) RT-PCR of 
differentiated ITSCs showing the down-regulation of Nestin and the up-regulation of MAP-2, Synaptophysin, 
AMPA receptor subunit 1, NMDA Receptor subunit 1, vesicular glutamate transporter 1, and glutamate 
metabotropic receptor 1 after neuronal differentiation at the mRNA level. RPLP0 served as housekeeping 
gene. NTC: non-template-control. The grouped gels were cropped from different parts of the same gel or from 
different gels, full-length gels are shown in the Supplementary Fig. S1. (l,m) Most ITSC-derived neurons were 
vGlut2+.
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Stimulation with TNF-α leads to significantly increased nuclear translocation of NF-κB-p65 
in ITSC-derived glutamatergic neurons. After validating human ITSC-derived neurons as a model 
system for studying the role of NF-κB during maturation, we investigated the potential of TNF-α to stimulate 
NF-κB in these neurons. Stimulation of ITSC-derived neurons with TNF-α for 30 minutes or 1 hour resulted 
in nuclear translocation of NF-κB-p65 (Fig. 4a, arrowheads) in comparison to untreated neurons or 24 h of 
Figure 2. ITSCs differentiate into glutamatergic neurons after transplantation into ex vivo-cultivated murine 
organotypic hippocampal slices. (a) Schematic view showing experimental design of ITSC-transplantation into 
organotypic hippocampal slices. (b) Immunocytochemistry showing differentiation of ITSCs into MAP-2 and 
Gat-1 positive neurons, indicating successful integration of transplanted ITSCs into organotypic hippocampal 
slices. (d) Schematic view showing the transplantation procedure of GFP-positive ITSCs into organotypic 
hippocampal slices. E: GFP+-ITSCs integrated within the dentate gyrus of the hippocampus and exhibited a 
neuronal phenotype accompanied by expression of vGlut2 and Synaptophysin.
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Figure 3. Stimulation of glutamatergic neurons derived from ITSCs leads to significantly increased nuclear 
translocation of NF-κB-p65. (a,b) Immunocytochemistry and respective quantification of nuclear mean 
integrated density of NF-κB-p65 revealed significantly increased nuclear translocation of NF-κB-p65 in ITSC-
derived neurons after glutamate (GLU)-dependent stimulation (arrowheads) compared to control (arrows). 
Mean values were normalized to the highest value. (c,d) AMPA-dependent stimulation resulted in significantly 
increased nuclear translocation of NF-κB-p65 in ITSC-derived neurons (arrowheads) compared to control 
(arrows). Mean values were normalized to the highest value. (e,f) Pre-treatment of ITSC-derived neurons with 
dibenzocyclohepteneimine (MK-801) or 6-cyano-7-nitroquinoxaline-2, 3-dione (CQNX) prior to GLU or 
AMPA-treatment led a significant decrease in nuclear translocation of NF-κB-p65 (arrows) compared to GLU 
or AMPA-dependent stimulation (arrowheads). Mean values were normalized to the highest value. Statistical 
analysis was performed using Graph Pad Prism 5. Normality of the data sets was refuted after analysis using 
Kolmogorov-Smirnov and Shapiro-Wilk normality tests. Non-parametric Mann-Whitney test was further used 
(***p ≤ 0.001), error bars indicate the standard error of the mean (SEM).
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TNF-α-treatment (Fig. 4a, arrows). Quantification of the NF-κB-p65 nuclear mean integrated density clearly 
validated these dynamics by showing a highly significant increase in nuclear NF-κB-p65 fluorescence after 
30 minutes (93,96% ± 6,04%) and 1 hour (88,00% ± 12,00%) of TNF-α-treatment compared to untreated controls 
(<20%) (Fig. 4b). Accordingly, stimulation of ITSC-derived neurons with TNF-α for 24 hours did not result in a 
significantly different nuclear NF-κB-p65 fluorescence intensity compared to control (Fig. 4b).
TNF-α-pre-treatment of human ITSC-derived glutamatergic neurons leads to increased 
NF-κB-p65-activity upon oxidative stress insult. We further analyzed the effect of H2O2-mediated 
oxidative stress insult on the activity of NF-κB-p65 in ITSC-derived neurons. Application of H2O2 for 25 h on 
human glutamatergic neurons differentiated for 30 days led to significantly increased nuclear translocation of 
NF-κB-p65 in comparison to control. In order to analyze a potential neuroprotective role of NF-κB, we per-
formed a pre-treatment using 10 ng/ml TNF-α during 2 hours prior to oxidative stress insult.
Figure 4. TNF-α-dependent stimulation of glutamatergic neurons derived from ITSCs leads to nuclear 
transloaction of NF-κB-p65. (a) Immunocytochemistry of ITSC-derived neurons (30 days of differentiation) 
showed nuclear translocation of NF-κB-p65 after treatment with TNF-α for 30 min or 1 h (arrowheads), 
whereas control and 24 h-TNF-α-treatment did not result in nuclear translocation of NF-κB-p65 (arrows).  
(b) Quantification of nuclear mean integrated density of NF-κB-p65 confirmed the significant increase in 
nuclear NF-κB-p65 after TNF-α-treatment of ITSC-derived neurons for 30 min or 1 h compared to 24 h 
and untreated control. Mean values were normalized to the highest value. Statistical analysis was performed 
using Graph Pad Prism 5. Normality was refuted after analysis using Kolmogorov-Smirnov and Shapiro-Wilk 
normality tests. Non-parametric Mann-Whitney test was further used. ***p ≤ 0.001, error bars indicate the 
standard error of the mean (SEM).
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Notably, TNF-α-pre-treatment of ITSC-derived glutamatergic neurons followed by H2O2-mediated oxidative 
stress resulted in a significant increase in nuclear translocation of NF-κB-p65 compared to the H2O2 alone or 
control (Fig. 5a,b, arrowheads). We further applied pyrrolidine dithiocarbamate (PDTC) as a control for guided 
inhibition of NF-κB. Pre-treatment of the cultivated neurons with PDTC for 1 hour followed by application 
of TNF-α or sole PDTC-treatment did not result in changes of nuclear translocation of NF-κB-p65 (Fig. 5a,b, 
arrows). Quantification of the nuclear mean integrated density for p65 indicated a small but significant increase 
in nuclear NF-κB-p65 in both treatments compared to the untreated negative control (Fig. 5b).
ITSC-derived glutamatergic neurons are protected from oxidative stress-mediated cell death 
via TNF-α-dependent activation of NF-κB-p65. Determining the physiological consequences of 
TNF-α-dependent activation of NF-κB-p65 during oxidative stress, we analysed the death rate of ITSC-derived 
Figure 5. Treatment of ITSC-derived glutamatergic neurons with TNF-α prevents from oxidative stress-
mediated cell death in a sex-dependent manner. (a) Immunocytochemistry of ITSC-derived neurons after 
30 days of differentiation, after treatment with H2O2 alone, TNF-α-pre-treatment prior to H2O2, PDTC alone 
and PDTC followed by TNF-α against NF-κB-p65. (b) Quantification of immunocytochemical assays showed 
significantly increased nuclear translocation of NF-κB-p65 after treatment with TNF-α alone and TNF-α prior 
to H2O2 compared to H2O2 alone and untreated control. Pre-treatment of ITSC-derived neurons with PDTC for 
one hour followed by TNF-α-treatment did not result in significantly different amounts of nuclear NF-κB-p65 
compared to PDTC alone. Mean values were normalized to the highest value. (c) Quantification of neuronal cell 
death showed significant death after oxidative stress insult (H2O2) compared to TNF-α/ H2O2, TNF-α, PDTC, 
PDTC/TNF-α and untreated control (n = 6). (d) Quantification of neuronal cell death after oxidative stress 
(H2O2), TNF-α-pre-treatment, TNF-α, PDTC, PDTC/ TNF-α and untreated control comparing sex differences 
(n = 3 males, n = 3 females). Data were showed not to be normally distributed using Kolmogorov-Smirnov and 
Shapiro-Wilk normality tests. Non-parametric Kruskal-Wallis test was further used (p ≤ 0.001), and Tukey’s 
post-hoc test (**p ≤ 0.01, ***p ≤ 0.001). Mean ± SEM (standard error of the mean).
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neurons after treatment with H2O2 or H2O2 after TNF-α-pre-treatment. H2O2-mediated oxidative stress led to 
robust and significant apoptosis of glutamatergic neurons compared to untreated control (Fig. 5c). Notably, 
this H2O2-mediated increase in apoptosis was significantly reduced down to a level similar to control upon 
TNF-α-pre-treatment prior to the oxidative stress insult (Fig. 5c). Application of TNF-α alone did not affect the 
survival of ITSC-derived neurons nor did the PDTC treatment, or the PDTC treatment followed by TNF-α in 
comparison to control (Fig. 5c).
Sensitivity of glutamatergic neurons to ROS-mediated cell death and neuroprotection via 
NF-κB-p65 is dependent on the sex of the ITSC-donor. Investigating the effects of TNF-α-treatment 
on H2O2-mediated death of ITSC-derived neurons in more detail, we analysed the amount of apoptotic cells 
after oxidative stress and TNF-α-dependent neuroprotection in dependence to the sex of the ITSC-donor. We 
observed a significant increase in cell death of neurons differentiated from female ITSC-donors compared to 
their male counterparts, indicating an elevated sensitivity of human female glutamatergic neurons to oxidative 
stress (Fig. 5d). Pre-treatment of ITSC-derived neurons from female donors with TNF-α led to a significant and 
complete neuroprotection against H2O2-mediated cell death. Although neurons from male ITSC-donors were 
likewise protected against cell death via exposure to TNF-α, we observed a 2-fold increase in TNF-α-dependent 
neuroprotection in female ITSC-derived neurons compared to those differentiated from male ITSCs. These 
findings not only demonstrate a NF-κB-dependent neuroprotection of ITSC-derived neurons against oxidative 
stress-mediated cell death, but emphazise the dependence on its sensitivity to the sex of the ITSC-donor.
TNF-α-mediated neuroprotection of ITSC-derived neurons is accompanied by sex-specific 
expression of NF-κB target genes. To investigate the role of NF-κB-p65 in protection of ITSC-derived 
neurons from H2O2-mediated death in more detail, expression of NF-κB target genes was assessed by qPCR. 
Treatment of ITSC-derived neurons with H2O2 or TNF-α followed by H2O2 led to significantly increased expres-
sion levels of cAMP-dependent protein kinase catalytic subunit alpha (PKAcatα) compared to control. We further 
observed a significant increase in PKAcatα expression levels in male ITSCs-derived neurons compared to those 
differentiated from female ITSCs after TNF-α/H2O2-treatment (Fig. 6a). On the contrary, we observed a signifi-
cant increase in manganese superoxide dismutase (Mn-SOD, SOD2) mRNA levels only in female ITSCs-derived 
neurons upon exposure to TNF-α, H2O2 and TNF-α/H2O2 compared to control (Fig. 6b). Expression levels of 
cellular inhibitor of apoptosis protein-1 and 2 (c-IAP1 and c-IAP2) showed the tendency to be elevated in male 
ITSCs-derived neurons after TNF-α/H2O2-treatment compared to their female counterparts (Fig. 6c,d) however 
no significant alteration was detectable. Treatment with TNF-α, H2O2 and TNF-α/H2O2 further resulted in sig-
nificantly increased expression levels of insulin-like growth factor 1 (IGF1) in ITSCs-derived neurons compared 
to control (Fig. 6e), although no significant sex-dependent differences were observable. Female ITSCs-derived 
neurons showed significantly increased expression levels of IGF2 after H2O2 and TNF-α/H2O2-treatment com-
pared to control (Fig. 6f), while no expression was detectable in male counterparts. However, sole treatment with 
TNF-α resulted in significantly increased expression levels of IGF2 in neurons from male and female donors 
compared to control (Fig. 6F). These findings strongly suggest a sex-specific NF-κB-p65 target gene expression in 
dependence to TNF-α-mediated neuroprotection during oxidative stress.
Discussion
The present study describes for the first time a neuroprotective role of NF-κB-p65 in human ITSC-derived glu-
tamatergic neurons after oxidative stress insult in a sex-specific manner. We successfully differentiated human 
neural crest-derived inferior turbinate stem cells into MAP-2+/NF200+/Synaptophysin+/vGlut2+-glutamatergic 
neurons by application of a directed differentiation assay or via transplantation into organotypic mouse hip-
pocampal slice cultures. Extending our previous findings depicting vesicle recycling and calcium spiking of 
ITSC-derived neurons38, we validated their functionality by showing increased NF-κB-activity upon stimulation 
with the excitatory neurotransmitter glutamate or its agonist AMPA. Inhibitor controls using CQNX and MK-801 
led to a decrease in glutamate or AMPA-dependent stimulation of NF-κB-activity, further validating the specific-
ity of the respective receptors. In accordance to our findings, stimulation of ionotropic glutamate receptors was 
shown to activate NF-κB in primary rat cerebellar granule neurons11,12. Given the pivotal role of NF-κB signalling 
in key elements for neuronal morphology like neurite growth14, dendritic spine formation15, axonal outgrowth16 
and synaptic plasticity17,18, our data suggest the participation of NF-κB in the normal physiology of the human 
nervous system.
In addition to its AMPA- and glutamate-dependent stimulation, we also observed a significant increase in 
NF-κB-activity in ITSC-derived neurons after treatment with TNF-α. In canonical NF-κB-signalling, recog-
nition of stimuli like cytokines or neurotransmitters leads to phosphorylation of IκB kinases40,41, in turn result-
ing in phosphorylation, polyubiquitination and 26S-proteasome-mediated degradation of IκBs. Demasking of 
the nuclear translocation signal region of p50/p65 by degradation of IκBs is subsequently followed by trans-
location of p50/p65 into the nucleus and activation of target gene expression by binding to κB elements18,42–45. 
TNF-α is one of the best characterized cytokines inducing this pathway, and its receptors TNFR1 and TNFR2 are 
widely expressed in the nervous system both in neurons and glia46–48. Besides its modulatory effects of neuronal 
responses to excitotoxic and hypoxic insults in the nervous system49, the absence of TNFR was shown to result in 
an increased neuronal damage following either ischemic or kainic acid induced excitotoxic damage50. In mouse 
NSCs, TNF-α-mediated NF-κB signalling was reported to be required for initial neuronal differentiation29. In 
accordance, preliminary data from our lab suggests that NF-κB-c-Rel might be the relevant subunit for glutama-
tergic differentiation and not NF-κB-p65, having no significant differences with respect to sex (unpublished data). 
Extending these findings, mature human ITSC-derived glutamatergic neurons revealed a significantly increased 
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nuclear translocation of NF-κB-p65 after TNF-α-stimulation in the present study, indicating the crucial role of 
NF-κB-signalling during stem cell-based neuronal differentiation and neuroprotection in humans.
Being a major cause of several neurologic diseases and brain damage20, oxidative stress is known to be directly 
caused by Alzheimer’s disease via amyloid beta peptide-dependent production of hydrogen peroxide through 
metal ion reduction51,52. In Parkinson’s disease, free radicals accumulate in the substantia nigra pars compacta, 
resulting in the formation of 6-hydroxydopamine, in turn leading to the generation of superoxide53,54. In the 
present study, H2O2-mediated oxidative stress led to cell death of human ITSC-derived glutamatergic neurons. 
Although NF-κB is known to be activated by oxidative stress in the nervous system20, several studies indi-
cated its neuroprotective role in murine cells. Here, Heck and colleagues demonstrated an Insulin-like growth 
factor-1-mediated neuroprotection of rat primary cerebellar neurons against oxidative stress directly associated 
to activation of NF-κB55. Erythropoietin-mediated neuroprotection of rat cerebral cortical cell cultures from 
oxidative stress was also shown to occur in an NF-κB-dependent manner56. On the contrary, Zou and colleagues 
demonstrated TNF-α-treatment of rat hippocampal-entorhinal cortex slice cultures to result in increased neu-
rotoxicity to both glutamate and oxidative stress57. In the present study, TNF-α-pre-treatment led to a significant 
decrease in H2O2-mediated cell death of ITSC-derived human neurons accompanied by a significantly increased 
nuclear translocation of NF-κB-p65. Our data therefore demonstrate a key role of NF-κB-p65 in protection of 
human stem cell-derived neurons from oxidative stress, further emphasizing the importance of NF-κB-signalling 
in neuroprotection20,55,56.
Interestingly, we further observed a significantly elevated sensitivity of ITSC-derived neurons from female 
donors to oxidative stress-induced cell death and to NF-κB-dependent neuroprotection compared to neu-
rons from male donors. These findings were confirmed by a differential expression of NF-κB target genes in 
dependence to the sex of the ITSC-donor. Here, increased SOD2 mRNA levels observed in female but not in 
male ITSC-derived neurons indicated a NF-κB-associated induction of SOD2 protecting against oxidative 
stress-induced neuronal apoptosis. Accordingly, SOD2 expression was described to be inducible by TNF-α, hav-
ing an anti-apoptotic role by directly reducing cellular ROS levels58. Next to SOD2, expression levels of IGF2 were 
significantly elevated only in female neurons after TNF-α/H2O2-treatment compared to control. IGF2 is known 
Figure 6. Quantitative polymerase chain reaction revealed sex-specific NF-κB-p65 target gene expression after 
TNF-α-dependent neuroprotection upon oxidative stress-insult. (a) qPCR analysis revealed increased PKAcatα 
mRNA levels after H2O2 alone, TNF-α-pre-treatment prior to H2O2 and TNF-α alone compared to untreated 
control, with a stronger effect for TNF-α/H2O2 in male compared to female ITSC-derived neurons. (b) SOD2 
mRNA levels significantly increased in female ITSC-derived neurons compared to control and compared to 
their male counterparts. (c) qPCR analysis showing c-IAP1 mRNA levels in male and female ITSC-derived 
neurons. (d) qPCR analysis showing c-IAP2 mRNA levels in male and female ITSC-derived neurons. (e) qPCR 
analysis showing significant increased IGF1 mRNA levels compared to control in male and female ITSC-derived 
neurons. (f) IGF2 mRNA levels were significantly elevated only in female-derived neurons compared to control. 
Non-parametric Mann Whitney test (*p ≤ 0.05), mean ± SEM (standard error of the mean, n = 3 males, n = 3 
females). Nd: Not detectable. Ct values were normalized to reference genes β-actin and RPLP0 (Ribosomal 
Protein Lateral Stalk Subunit P0).
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to promote synapse formation and spine maturation in the mouse brain59. Within a mouse model of Alzheimer’s 
disease, IGF2 administration rescued spine formation and synaptic transmission in the hippocampus60. In 
accordance to the present findings, IGF2 was reported to have an antioxidant and neuroprotective effect on oxi-
dative damage and mitochondrial function in cultured adult rat cortical neurons61,62. In contrast to their female 
counterparts, male ITSC-derived neurons showed a significant increase in the expression level of PKAcatα after 
TNF-α/H2O2-treatment. Interestingly, we observed no significantly altered expression levels of the antiapoptotic 
proteins c-IAP1 and c-IAP2, known mediators of TNF-α-dependent neuroprotection63. With PKAcatα being 
an essential regulator in learning and memory by transducing synaptic responses through CREB signalling64,65 
and controlling synaptic incorporation of AMPA receptors66, PKA-activity may directly contribute to the neuro-
protective effects observed here. Although being a matter of debate, sex-dependencies in stem cell biology have 
already been shown in terms of autosomal gene expression67 and proliferation68, particularly regarding mouse 
NSCs69,70. Compared to their male counterparts, female muscle-derived stem cells were reported to have higher 
muscle regeneration efficiency in mice71. In terms of neuroinflammation and neuroprotection, sex-dependent 
differences between patients have been likewise reported in ischemic stroke4, PD2, or AD3. While female AD 
patients were described to have an increased risk of developing AD3,6, PD was shown to have a greater prevalence 
in male patients2. These data are in agreement with sex-specific differences found in adult murine microglia, 
where female microglia exhibited a neuroprotective phenotype upon ischemic insult, which was retained after 
being transferred into male brains72. In addition sex-specific differences in the expression of iNOS and NF-κB 
were previously reported in human polymorphonuclear neutrophils, being higher in female than in male cells73. 
In line with these findings, our data indicate for the first time a direct sex-dependent difference in neuroprotec-
tion of human stem cell-derived neurons against oxidative stress mediated by NF-κB-signalling.
In summary, we provide here evidence that NF-κB-p65 is a key player in neuroprotection of human neurons 
against oxidative stress in a sex-dependent manner. We demonstrate a sex-dependent difference of stress response 
and TNF-α-mediated neuroprotection, with a strong increase of both H2O2-mediated cell death as well as neu-
roprotection against cell death in female derived neurons compared to their male counterparts (Fig. 7). These 
differences were emphasized by the sex-specific differential expression of NF-κB-p65 target genes SOD2 and 
IGF2 in TNF-α-dependent neuroprotection upon oxidative stress-insult. In line with our findings, increasing 
evidences pointing towards sex-specific differences in risk and severity of neurodegenerative diseases, such as 
Alzheimer’s disease. Since oxidative stress is directly associated to neurodegenerative diseases, but little is known 
about the underlying molecular mechanisms of neuroprotection, NF-κB-signalling may be a crucial parameter 
for treatment strategies and neuronal regeneration therapies.
Methods
All methods were performed in accordance to the relevant guidelines and regulations.
Isolation and Cultivation of ITSCs. ITSCs were isolated from adult human inferior turbinate tissue 
obtained by biopsy during routine surgery after informed consent according to local and international guidelines 
and cultivated as described previously36. The ethics board of the medical faculty of the University of Münster 
Figure 7. Sex-specific response to oxidative stress insult and NF-κB-mediated neuroprotection in human 
NCSC-derived neurons. Female ITSC-derived neurons responded with a higher sensitivity to oxidative stress-
induced neuronal death, and TNF-α-mediated neuroprotection compared to their male counterparts. TNF-
α-mediated neuroprotection led to an increase in NF-κB-p65 nuclear translocation, triggering differential 
expression of sex-specific NF-κB target genes.
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approved all the procedures described in this article (No. 2012–015-f-S). All experiments and methods were 
performed in accordance to the relevant guidelines and regulations. ITSCs were cultivated within the 3D blood 
plasma (BP) matrix37, and dissociated ITSCs were resuspended in Dulbecco’s modified Eagle’s medium/Ham 
F-12 (DMEM/F-12; Biochrom, Berlin, Germany, http://www.biochrom.de) supplemented with basic fibroblast 
growth factor-2 (FGF2; 40 ng/ml; Miltenyi Biotec), epidermal growth factor (EGF; 20 ng/ml; Miltenyi Biotec) and 
B27 supplement (Gibco) followed by supplementation with 10% of clinically accredited therapeutic human blood 
plasma (BP; obtained from Institut für Laboratoriums und Transfusionsmedizin, Bad Oeynhausen, Germany) 
and cultivated at 37 °C, 5% O2 and 5% CO2.
Neuronal differentiation. For neuronal differentiation, cells of six donors were expanded within the 3D 
BP matrix, were dissociated and resuspended in DMEM high glucose (Sigma-Aldrich) containing 200 mM 
L-glutamine (Sigma-Aldrich) and 10% foetal calf serum (Sigma-Aldrich) an plated at a density of 5 × 104 cells per 
24 well plate followed by cultivation at 37 °C, 5% CO2 and atmospheric O2 for 2 days. Afterwards, 1 μM dexameth-
asone (Sigma-Aldrich), 2 μM insulin (Sigma-Aldrich), 500 μM 3-isobutyl-1-methylxanthine (Sigma-Aldrich), 
200 μM indomethacin (Sigma-Aldrich) and 200 μM ethanol were added to the medium to induce neuronal 
differentiation (neuronal induction medium, NIM). After 9 days of differentiation cells were induced adding 
0.5 μM retinoic acid (Sigma Aldrich) and 1x N-2 supplement (Gibco, Darmstadt, Germany, http://www.invitro-
gen.com). Subsequently, the medium was changed by removing half of the volume, followed by addition of fresh 
pre-warmed NIM containing 1x N-2 supplement38. ITSCs were differentiated for 1 month, and further stimulated 
using different drugs, or treated for immunocytochemical and RT-PCR analysis.
Neuronal stimulation. After 30 days of differentiation neurons were exposed to the excitatory neuro-
transmitter glutamate (GLU) or its agonist α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA), the 
cytokine Tumour Necrosis Factor α (TNF-α, Calbiochem®), hydrogen peroxide (H2O2), and the NF-κB inhibitor 
pyrrolidine dithiocarbamate (PDTC)23. Before treatment with glutamate or AMPA, cells were washed three times 
with buffered control salt solution (CSS)74 containing 120 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 25 mM Tris 
HCl (pH 7.4), 15 mM D-glucose. For inhibitor controls cells were pre-incubated with either 1 μM dibenzocy-
clohepteneimine (MK-801, Tochris Bioscience, UK)75 or 50 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CQNX, 
Tochris Bioscience, UK)12 for 10 min at 37 °C, before 10 min treatment with glutamate or AMPA respectively. 
After treatment with different concentrations, cells were washed with CSS and incubated with complete medium 
for 45 min at 37 °C. Control cells received identical incubation times and washing steps with CSS12. The pulse with 
10 ng/ml TNF-α was performed for 30 min, 1 h, and 24 hours. For oxidative stress induction, 300 μM H2O2 were 
applied during 25 h and to analyse the neuroprotective role of NF-κB during oxidative stress, a pre-treatment 
with 10 ng/ml TNF-α was performed for 2 hours previous to the treatment with H2O2. Untreated control cells 
received identical incubation times. In order to confirm NF-κB activation due to TNF-α, a pre-treatment using 
100 μM PDTC for one hour was performed and samples were directly used or further treated with TNF-α for 
at least one hour. For Indirect immunofluorescence assay cells were fixed as described below. For Smart-seq. 2, 
cells were directly used after treatment, whose duration was 3 h for PDTC and TNF-α treatment as well as for the 
combination treatments.
Immunocytochemistry. Differentiated ITSCs were fixed for 15 min in phosphate-buffered 4% paraform-
aldehyde (PFA 4% pH 7.4) at room temperature (RT) followed by 3 wash steps in phosphate-buffered saline 
(1xPBS). The cells were permeabilized with 0.02% Triton X-100 and blocked using 5% of appropriate serum 
or 3% BSA for 30 minutes at RT, followed by incubation with primary antibodies for 1 hour at RT. Antibodies 
used were anti-neurofilament NF200 (1:200, N4142, Sigma-Aldrich), anti-MAP-2 (1:100, Sc-20172, Santa 
Cruz Biotechnology), anti-Synaptophysin (1:250, MAB5258, Merck Millipore), anti-vGlut2 (1:200, MAB5504, 
Millipore), anti-nestin (1:200, MAB5326, Millipore) anti-olig-2 (1:250, Q13516, R&D Systems), anti-NF-kappa B 
p65 (D14E12, Cell Signaling). The secondary fluorochrome-conjugated antibodies (1:300; goat anti-mouse Alexa 
555, goat anti-rabbit Alexa 555, donkey anti goat Alexa 555; Life Technologies) were incubated for 1 hour at RT. 
Nuclear counterstaining was performed with 49,6-diamidino-2-phenylindole (DAPI; 1 μg/ml; Sigma-Aldrich) for 
15 min at RT. Fluorescence imaging was performed using a confocal laser scanning microscope (LSM 780; Carl 
Zeiss, Jena, Germany) and analyzed using ZEN software from the same provider or ImageJ76.
Reverse transcription Polymerase Chain Reaction. Total RNA was isolated using the TRI Reagent 
(Sigma-Aldrich) according to the manufacture’s guidelines. Quality and concentration of RNA were assessed via 
Nanodrop ultraviolet spectrophotometry. cDNAs were synthesized by reverse transcription using the First Strand 
cDNA Synthesis Kit (Fermentas Life Sciences). PCR was performed using the GoTaq (Promega) according to 
the manufacturer’s guidelines and 10 µM primers (Sigma-Aldrich). The cycling conditions comprised an initial 
denaturation of 1 min at 94 °C and 35–38 cycles of 15 s at 94 °C, 15 s at 60 °C, and 20 s at 72 °C followed by a final 
elongation for 1 min at 72 °C. For primer sequences see Table 1.
SMART-Seq2. For full-length cDNA generation, the protocol recently described by Picelli et al.77 slightly 
modified was applied. Approximately 20000 cells/treatment ITSC-derived glutamatergic neurons were used. Cells 
were harvested by centrifugation (5000 g for 5 min at RT) and directly lysed with an adjusted amount of lysis 
buffer (RNase inhibitor, 0.2% Triton X-100). Afterwards the annealing mix containing AccuStart Taq Polymerase 
HiFi (Quanta bio), oligo-dT primer, dNTP-mix, was added to the cell lysate. Probes were incubated 3 min at 72 °C, 
and the reverse transcription-mix containing SuperScript II reverse transcriptase (Thermo Fisher Scientific) was 
added. Reverse transcription, relying on template-switching reaction was performed. The cycling program com-
prised an initial denaturation of 90 min at 42 °C, following by 9 cycles of 2 min at 50 °C and 2 min at 42 °C followed 
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by a final elongation for 15 min at 70 °C. The PCR pre-amplification mix was added to the first-strand reaction. 
PCR pre-amplification-cycling-program comprised an initial denaturation of 3 min at 98 °C and 21 cycles of 20 s 
at 98 °C, 15 s at 67 °C, and 6 min at 72 °C followed by a final elongation for 5 min at 72 °C.
Real-time PCR. All Quantitative polymerase chain reactions (qPCR) were performed in triplicate using 
Platinum SYBR Green qPCR Super-Mix UDG (Invitrogen), according to the manufacturer’s guidelines, and 
assayed with a Rotor Gene 6000 (Qiagen). Primers used are listed in Supplementary Table S1.
Hippocampal Slice Culture and transplantation of ITSCs on organotypic hippocampal slice cul-
tures and Immunocytochemical analyzes. For organotypic hippocampal slice culture, hippocampi of 
mice (postnatal day 5) were isolated and rapidly cut perpendicularly to the longitudinal axis into 400 µm thick 
slices with a McIllwain Tissue Chopper. Slices were cultivated on culture plate inserts according to De Simoni and 
Yu78. In parallel ITSCs were transduced with lentivirus pFUGW containing a constitutively expressed GFP-gene 
under control of human ubiquitin c promoter. GFP+-ITSCs and ITSCs were cultivated as neurospheres for 2 days. 
7 days after slice preparation, dissociated cells (1 × 104) were dropped onto each slice following by cultivation for 
14 days at 37 °C and 5% CO2. Slices were cut off from the membrane and free-floating fixated in PFA 4% for 1 h 
at 4 °C on agitation. After 3 washes with PBS, slices were incubated in PBS containing 0.1% Triton X-100 and 
5% goat serum for 1 hour at RT. Slices containing transplanted GFP+-ITSCs were double immuno-labeled with 
anti-GFP (1:1000, sc-9996, Santa Cruz) combined with anti-synaptophysin (1:200) or anti-vGlut2 (1:200). Slices 
containing transplanted non transduced ITSCs were free-floating stained with anti-human nuclei (HuNu, 1:200, 
MAB1281, Millipore) combined with anti-MAP-2 (1:100), or anti-Gat1 (1:200, AB1570, Millipore) for 48 h at 
4 °C. Respective secondary fluorochrome-conjugated antibodies (goat anti-mouse Alexa 555, goat anti-rabbit 
Alexa 555, donkey anti-rabbit Alexa 488, donkey anti-mouse Alexa 488) were applied for 2 h at RT under exclu-
sion of light. Nuclei were stained with TOTO®-3 Iodide (642⁄660 nm, life technologies).
Cell Counting and Statistics. Quantification of immunofluorescence staining was performed for mini-
mum 3 different donors. For each time point 6–12 pictures were analysed per donor, where the mean of the 
nuclear integrated density was measured by defining the region of interest with the nuclear DNA channel using 
ImageJ76. For analysis of neuronal survival the same channel was used to analyse the nuclear chromatin mor-
phology. Nonviable neurons were recognized by nuclear condensation and/or fragmented chromatin. In phase 
contrast images, those neurons were irregularly shaped with shrunken cell body and/or disrupted neurites. The 
number of viable and nonviable neurons was counted in four to five field pictures and death rate was calculated. 
Data was further analysed for statistics using Past379 and/or GraphPad Prism 5 (GraphPad software, La Jolla, CA, 
http://www.graphpad.com). Normality of the data sets was refuted after analysis using Kolmogorov-Smirnov and 
Shapiro-Wilk normality tests. Non-parametric Kruskal-Wallis test was used to compare the medians between the 
different data sets for the different donors (***p ≤ 0.001). Non-parametric Mann-Whitney test was used to com-









AMPA receptor subunit 1 GGGCGATAATTCAAGTGTTCA
Rev-AMPA receptor subunit 1 GGCTCCGTATTTTCCATCAC
NMDA Receptor subunit 1 GCTCCTCGAGAAGGAGAACA
Rev- NMDA Receptor subunit 1 GCCATTGTAGATGCCCACTT
Vesicular glutamate transporter 1 CACAAGACTCGGGAGGAGTG
Rev- Vesicular glutamate transporter 1 GCCTCATCCTCCATTTCGCT
Glutamate metabotropic receptor 1 AGCTGCTGATTTCTCAGCCAA
Rev- Glutamate metabotropic receptor 1 GCCTCCAACATTGGAATGGA
Tyrosine Hydroxylase CCGTGCTAAACCTGCTCTTC
Rev- Tyrosine Hydroxylase CGCACGAAGTACTCCAGGT
Choline Transporter GGCACAGCTGAAGCAGTTTA
Rev- Choline Transporter CCCATGCGTTTTCCATAGAT
Serotonin transporter CTCCGAGGACAACATCACCT
Rev- Serotonin transporter CAGAGGTCTTGACGCCTTTC
RPLP0 (Ribosomal Protein Lateral Stalk Subunit P0) TGGGCAAGAACACCATGATG
Rev-RPLP0 AGTTTCTCCAGAGCTGGGTTGT
Table 1. Primers sequences for reverse transcription polymerase chain reaction.
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